Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2022

Feb 25, 2022

29995_dirs_2022-02-24_35d7c054-7b8a-4cb6-bb2e-25ff363622eb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2022-02-22

Reporting Person: DEBEL MARLENE (EVP & Chief Risk Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-22 Common Stock A 5330 Acquired 48442 Direct
2022-02-22 Common Stock A 11313 Acquired 59755 Direct
2022-02-22 Common Stock F 4098 $68.96 Disposed 55657 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-22 Employee Stock Options (right to buy) $68.96 A 15986 Acquired 2032-02-21 Common Stock (15986.0) Direct

Footnotes

F1: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

F2: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.

F3: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.

F4: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.